A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Two Fixed-dose Leucine and Sildenafil Combinations (NS-0300) or Two Fixed-dose Leucine, Sildenafil and Metformin Combinations (NS-0200) Versus Placebo on Body Weight in Obesity

Trial Profile

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Two Fixed-dose Leucine and Sildenafil Combinations (NS-0300) or Two Fixed-dose Leucine, Sildenafil and Metformin Combinations (NS-0200) Versus Placebo on Body Weight in Obesity

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Dec 2017

At a glance

  • Drugs Leucine/metformin/sildenafil (Primary) ; Leucine/sildenafil (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Sponsors NuSirt Biopharma
  • Most Recent Events

    • 12 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top